These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
703 related items for PubMed ID: 7784993
1. [Therapy of primary chronic glomerulonephritis]. Risler T, Braun N, Erley CM. Ther Umsch; 1994 Dec; 51(12):807-12. PubMed ID: 7784993 [Abstract] [Full Text] [Related]
5. [Diagnosis and therapy of chronic glomerulonephritis in long-term follow-up]. Sinn W. Z Urol Nephrol; 1986 Feb 30; 79(2):59-66. PubMed ID: 3705778 [Abstract] [Full Text] [Related]
6. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis]. Voznesenskaia TS, Sergeeva TV. Ter Arkh; 2002 Feb 30; 74(6):31-3. PubMed ID: 12136479 [Abstract] [Full Text] [Related]
10. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy]. Branten AJ, Wetzels JF. Ned Tijdschr Geneeskd; 1998 Dec 26; 142(52):2832-8. PubMed ID: 10065257 [Abstract] [Full Text] [Related]
11. The changing pattern of glomerulonephritis in Singapore over the past two decades. Woo KT, Chiang GS, Pall A, Tan PH, Lau YK, Chin YM. Clin Nephrol; 1999 Aug 26; 52(2):96-102. PubMed ID: 10480220 [Abstract] [Full Text] [Related]
12. [Effect of cyclosporin A on renal function in patients with glomerulonephritis]. Heering P, Schneider A, Grabensee B, Plum J. Dtsch Med Wochenschr; 2001 Oct 05; 126(40):1093-8. PubMed ID: 11588659 [Abstract] [Full Text] [Related]
13. [Minimal change glomerulonephritis, diffuse mesangioproliferative glomerulonephritis and focal and segmental glomerular sclerosis and hyalinosis]. Belovezhdov N. Vutr Boles; 1984 Oct 05; 23(4):42-6. PubMed ID: 6506660 [Abstract] [Full Text] [Related]
14. T cell subsets in glomerulonephritis. Lin CY, Yang YM, Fu YK. Int J Pediatr Nephrol; 1986 Oct 05; 7(2):63-8. PubMed ID: 3487514 [Abstract] [Full Text] [Related]
15. Pharmacologic management of adult idiopathic nephrotic syndrome. Alaniz C, Brosius FC, Palmieri J. Clin Pharm; 1993 Jun 05; 12(6):429-39. PubMed ID: 8403814 [Abstract] [Full Text] [Related]
16. [The immunosuppressive therapy of chronic (Bright's) nephritis]. Krasnova TN, Shilov EM. Ter Arkh; 1993 Jun 05; 65(6):88-93. PubMed ID: 8378860 [No Abstract] [Full Text] [Related]
17. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis. Dumoulin A, Hill GS, Montseny JJ, Meyrier A. Am J Kidney Dis; 2003 Jan 05; 41(1):38-48. PubMed ID: 12500220 [Abstract] [Full Text] [Related]
18. Relapse of nephrotic syndrome following remission for 20 years. Cuoghi D, Vangelista A, Baraldi A, Cheli E. Int J Pediatr Nephrol; 1983 Sep 05; 4(3):211-4. PubMed ID: 6315615 [Abstract] [Full Text] [Related]
19. [Modes of clinical presentation of glomerular diseases]. Dervaux T, Moulin B. Rev Prat; 2003 Nov 30; 53(18):2013-21. PubMed ID: 15008215 [Abstract] [Full Text] [Related]
20. A clinician's view of the classification of glomerulonephritis. Cameron JS. Perspect Nephrol Hypertens; 1973 Nov 30; 1 Pt 1():63-79. PubMed ID: 4620928 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]